Fine-tuning neuromodulation by adenosine

Trends in Pharmacological Sciences

Volumn 21, Issue 9, 2000, Pages 341-346

  Sebastião, Ana M ^a   Ribeiro, J Alexandre ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; CALCITONIN GENE RELATED PEPTIDE; MEMBRANE RECEPTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPEPTIDE; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE; VASOACTIVE INTESTINAL POLYPEPTIDE;

4 AMINOBUTYRIC ACID RELEASE; ACETYLCHOLINE RELEASE; ANIMAL TISSUE; DESENSITIZATION; HIPPOCAMPUS; NERVE ENDING; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SYNAPTIC TRANSMISSION;

ADENOSINE; ANIMALS; HUMANS; NERVOUS SYSTEM PHYSIOLOGY; NEUROPEPTIDES; RECEPTORS, PURINERGIC P1;

EID: 0034284203     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(00)01517-0     Document Type: Review

References (50)

1. 2 receptor mediated excitatory actions of adenosine in the nervous system. Prog. Neurobiol. 48:1996;167-189.
2. 2A receptors. Prog. Neurobiol. 59:1999;355-396.
3. Nyce J.W. Insight into adenosine receptor function using antisense and gene-knockout approaches. Trends Pharmacol. Sci. 20:1999;79-83.
4. 2B receptors. Pharmacol. Rev. 1997;381-402.
5. 3 receptors: novel ligands and paradoxical effects. Trends Pharmacol. Sci. 19:1998;184-191.
6. Ferré S.et al. Adenosine-dopamine receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20:1997;482-487.
7. 2A receptor antagonists as new agents for the treatment of Parkinson's disease. Trends Pharmacol. Sci. 18:1997;338-344.
8. Correia-de-Sá P.et al. Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve endings of the rat. Br. J. Pharmacol. 103:1991;1614-1620.
9. Cunha R.A.et al. Preferential activation of excitatory adenosine receptors at rat hippocampal and neuromuscular synapses by adenosine formed from released adenine nucleotides. Br. J. Pharmacol. 119:1996;253-260.
10. 2A receptor interactions with receptors for other neurotransmitters and neuromodulators. Eur. J. Pharmacol. 375:1999;101-113.
11. 2A-facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm. J. Neurophysiol. 76:1996;3910-3919.
12. 1 receptors prevents, a facilitatory action of calcitonin gene-related peptide in the rat hippocampus. Br. J. Pharmacol. 129:2000;374-380.
13. 3H]-acetylcholine release from rat motor nerve endings. Br. J. Pharmacol. 111:1994;582-588.
14. 2-adenosine receptor activation. Neurosci. Lett. 151:1993;21-24.
15. Sattin A.et al. Regulation of cyclic adenosine 3′-5′-monophosphate levels in guinea pig cerebral cortex by interaction of α adrenergic and adenosine receptor activity. J. Pharmacol. Exp. Ther. 192:1975;22-32.
16. Fredholm B.B.et al. α-Adrenoceptor stimulation, but not muscarinic stimulation, increases cyclic AMP accumulation in brain slices due to protein kinase C mediated enhancement of adenosine receptor effects. Acta Physiol. Scand. 131:1987;543-551.
17. Priller J.et al. Stimulation of P2Y-purinoceptors on astrocytes results in immediate early gene expression and potentiation of neuropeptide action. Neuroscience. 85:1988;521-525.
18. 3H]-GABA release from rat hippocampal synaptosomes. Br. J. Pharmacol. 127:1999;30P.
19. Acsády L.et al. Correlated morphological and neurochemical features identify different subsets of vasoactive intestinal polypeptide-immunoreactive interneurons in the rat hippocampus. Neuroscience. 73:1996;299-315.
20. Wang H.-L.et al. Vasoactive intestinal polypeptide enhances the GABAergic synaptic transmission in cultured hippocampal neurons. Brain Res. 746:1997;249-300.
21. Rosenberg P.A., Li Y. Vasoactive intestinal peptide regulates extracellular adenosine levels in rat cortical cultures. Neurosci. Lett. 200:1995;93-96.
22. Wright R.A., Schoepp D.D. Differentiation of group 2 and group 3 metabotropic glutamate receptor cAMP responses in the rat hippocampus. Eur. J. Pharmacol. 297:1996;275-282.
23. Schaad N.C.et al. Accumulation of cyclic AMP elicited by vasoactive intestinal peptide is potentiated by noradrenaline, histamine, adenosine, baclofen, phorbol esters and ouabain in mouse cerebral cortical slices: studies on the role of arachidonic acid metabolites and protein kinase C. J. Neurochem. 53:1989;1941-1951.
24. Sakai K., Saito K. Synergism between low-dose nicorandil and neuropeptides on adenosine-induced vasodepression in rats. Eur. J. Pharmacol. 345:1998;279-284.
25. 2A receptor activation modulates nicotinic autoreceptor function at the rat neuromuscular junction. Eur. J. Pharmacol. 271:1994;349-355.
26. Winder D.G., Conn P.J. Activation of metabotropic glutamate receptors increases cAMP accumulation in hippocampus by potentiating responses to endogenous adenosine. J. Neurosci. 13:1993;38-44.
27. 2B adenosine receptor-stimulated cyclic AMP accumulation. Neurosci. Lett. 146:1992;231-233.
28. 1 receptor activation in the rat hippocampus. Br. J. Pharmacol. 121:1997;1541-1548.
29. 1 receptor by a facilitatory metabotropic glutamate receptor. J. Neurochem. 65:1995;615-621.
30. 1 and class II metabotropic glutamate receptors mediate shared presynaptic inhibition of retinotectal transmission. J. Neurophysiol. 82:1999;2947-2955.
31. 3 adenosine receptor activation inhibit presynaptic metabotropic glutamate receptor (mGluR) function and uncouple mGluRs from GTP-binding proteins. J. Neurosci. 18:1998;6138-6146.
32. 1-receptor interaction on noradrenaline release in rabbit brain cortex. Naunyn-Schmiedeberg's Arch. Pharmacol. 338:1988;53-61.
33. 1 receptors. Neuropharmacology. 38:1999;1511-1517.
34. 1 receptor activation. NeuroReport. 6:1995;1097-1100.
35. Costenla A.R.et al. An adenosine analogue inhibits NMDA receptor-mediated responses in bipolar cells of the rat retina. Exp. Eye Res. 68:1999;367-370.
36. de Mendonça J.A., Ribeiro J.A. Adenosine and neuronal plasticity. Life Sci. 60:1997;245-251.
37. 2A receptors of NMDA but not AMPA currents in striatal neurons. Br. J. Pharmacol. 130:2000;259-269.
38. 2A receptors in the rat hippocampus. Brain Res. 649:1994;208-216.
39. 2A adenosine receptors in the hippocampus and cortex of young adult and old rats. J. Neurophysiol. 82:1999;3196-3203.
40. 2A receptor in rat striatum. J. Neurochem. 69:1997;315-321.
41. Worley P.F.et al. Cholinergic phosphatidylinositol modulation of inhibitory, G protein-linked neurotransmitter actions: electrophysiological studies in rat hippocampus. Proc. Natl. Acad. Sci. U. S. A. 84:1987;3467-3471.
42. Sebastião A.M., Ribeiro J.A. Interactions between adenosine and phorbol esters or lithium at the frog neuromuscular junction. Br. J. Pharmacol. 100:1990;55-62.
43. 2 receptor-mediated responses in the rat hippocampus in vitro. Eur. J. Pharmacol. 362:1998;17-25.
44. 2 receptors. Eur. J. Pharmacol. Mol. Pharmacol. Sec. 227:1992;317-324.
45. 2 adenosine receptor cooperation. Eur. J. Neurosci. 8:1996;1124-1131.
46. 1 receptor-mediated responses in rat hippocampus. J. Neurosci. 17:1997;607-614.
47. Koizumi S.et al. Potentiation by adenosine of ATP-evoked dopamine release via a pertussis toxin-sensitive mechanism in rat phaeochromocytoma PC12 cells. Br. J. Pharmacol. 112:1994;992-997.
48. s proteins in type-1 cerebellar astrocytes. Glia. 26:1999;119-128.
49. Phillis J.W.et al. Purines and the nucleus tractus solitarius: effects on cardiovascular and respiratory function. Clin. Exp. Pharmacol. Physiol. 24:1997;738-9999.
50. Schwaninger M.et al. Stimulation of interleukin-6 secretion and gene transcription in primary astrocytes by adenosine. J. Neurochem. 69:1997;1145-1150.